Despite unprecedented advances in prostate cancer research, treatment, and precision medicine, many Black men continue to face barriers to accessing innovative therapies and participating in clinical research. Ensuring equitable access to breakthroughs requires stronger partnerships among researchers, healthcare providers, industry leaders, advocates, and the communities most affected by the disease.